Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,569 | 65,170 | 92,136 | 124,503 | 144,635 |
| Marketable Securities | 2,449 | 4,992 | 2,042 | N/A | 5,000 |
| Receivables | 13,822 | 13,020 | 15,345 | 12,630 | 11,859 |
| Inventories | 25 | 10,531 | 8,639 | 7,708 | 8,046 |
| Other current assets | 22,507 | 0 | 0 | 0 | 0 |
| TOTAL | $83,515 | $98,255 | $124,366 | $149,086 | $171,720 |
| Non-Current Assets | |||||
| PPE Net | 891 | 2,704 | 2,722 | 3,142 | 3,416 |
| Other Non-Current Assets | 570 | 10,615 | 12,339 | 41,586 | 40,328 |
| TOTAL | $1,461 | $13,319 | $15,061 | $44,728 | $43,744 |
| Total Assets | $84,976 | $111,574 | $139,427 | $193,814 | $215,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,991 | 4,676 | 10,826 | N/A | N/A |
| Accounts payable and accrued liabilities | 10,542 | 6,218 | 4,899 | 5,845 | 2,844 |
| Accrued Expenses | 18,306 | 21,239 | 20,986 | 19,465 | 21,255 |
| TOTAL | $32,891 | $32,758 | $37,422 | $27,195 | $26,076 |
| Non-Current Liabilities | |||||
| Long Term Debt | 83,639 | 83,363 | 84,653 | 78,491 | 78,055 |
| Other Non-Current Liabilities | 0 | 737 | 548 | 26,659 | 27,063 |
| TOTAL | $83,639 | $84,100 | $85,201 | $105,150 | $105,118 |
| Total Liabilities | $116,530 | $116,858 | $122,623 | $132,345 | $131,194 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29 | 29 | 29 | 26 | 26 |
| Common Shares | 73 | 73 | 1 | 65 | 65 |
| Retained earnings | -603,440 | -575,329 | -542,388 | -494,820 | -466,693 |
| Other shareholders' equity | -1 | -2 | 0 | 0 | 0 |
| TOTAL | $-31,554 | $-5,284 | $16,804 | $61,469 | $84,270 |
| Total Liabilities And Equity | $84,976 | $111,574 | $139,427 | $193,814 | $215,464 |